SCHEMBL22493653

SCHEMBL22493653

CC(C)(C)OC(=O)N1CCC2(CC1)Cc1c(Cl)cccc1[C@H]2N[S@+]([O-])C(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ STS P08842 4/20 0.43
▸ TSHR P16473 2/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ GPR119 Q8TDV5 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ NAMPT P43490 6/20 0.37
▸ PTPN2 P17706 1/20 0.36
▸ PTPN1 P18031 1/20 0.36
▸ PTPN6 P29350 1/20 0.36
▸ MAPK8 P45983 1/20 0.35
▸ ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22493652 1.00 STS (0.43) STSTSHRALOX15GPR119POLB
SCHEMBL29832487 1.00 STS (0.43) STSTSHRALOX15GPR119POLB
SCHEMBL21940374 0.90 TSHR (0.38) STSTSHRALOX15GPR119NAMPT
SCHEMBL29506184 0.90 TSHR (0.38) STSTSHRALOX15GPR119NAMPT
SCHEMBL29506188 0.90 TSHR (0.38) STSTSHRALOX15GPR119NAMPT
SCHEMBL21941112 0.90 TSHR (0.38) STSTSHRALOX15GPR119NAMPT
SCHEMBL29832328 0.90 TSHR (0.38) STSTSHRALOX15GPR119NAMPT
SCHEMBL23046025 0.89 GPR119 (0.39) TSHRALOX15GPR119NAMPTATM
SCHEMBL23046075 0.89 GPR119 (0.39) TSHRALOX15GPR119NAMPTATM
SCHEMBL31317540 0.89 GPR119 (0.39) TSHRALOX15GPR119NAMPTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113874363-B Protein tyrosine phosphatase inhibitors ARRAY生物制药公司 2024-11-12 — — CN disclosed
CN-114341124-B Protein tyrosine phosphatase inhibitors ARRAY生物制药公司 2024-09-20 — — CN disclosed
US-20240124453-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2024-04-18 — — US disclosed
US-11884664-B2 Protein tyrosine phosphatase inhibitors ARRAY BIOPHARMA INC. (US) 2024-01-30 — — US disclosed
US-11634417-B2 Protein tyrosine phosphatase inhibitors ARRAY BIOPHARMA INC. (US) 2023-04-25 — — US disclosed
US-11634417-B2 Protein tyrosine phosphatase inhibitors ARRAY BIOPHARMA INC. (US) 2023-04-25 — — US disclosed
US-20220251083-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2022-08-11 — — US disclosed
CN-113874363-A Protein tyrosine phosphatase inhibitors ARRAY生物制药公司 2021-12-31 — — CN disclosed
US-20200317665-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-10-08 — — US disclosed
US-20200317665-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-10-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11884664-B2 Protein tyrosine phosphatase inhibitors PPM1A, PPM1F, PPP5C STS 955/4885TSHR 3302/4885ALOX15 3934/4885
US-20200317665-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PPM1F, PPP5C STS 955/4885TSHR 3302/4885ALOX15 3934/4885
US-20240124453-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PPM1F, PPP5C STS 955/4885TSHR 3302/4885ALOX15 3934/4885
US-11634417-B2 Protein tyrosine phosphatase inhibitors PPM1A, PPM1F, PPP5C STS 955/4885TSHR 3302/4885ALOX15 3934/4885
US-20220251083-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PPM1F, PPP5C STS 955/4885TSHR 3302/4885ALOX15 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback